Evidence map›Paper›PMID 35534473›Full record

ArticleNature communications2022

Outpacing conventional nicotinamide hydrogenation catalysis by a strongly communicating heterodinuclear photocatalyst.

Linda Zedler, Pascal Wintergerst, Alexander K Mengele, Carolin Müller, Chunyu Li, Benjamin Dietzek-Ivanšić, Sven Rau

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Photocatalytic Reduction of Nicotinamide Co-factor by Perylene Sensitized RhChemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Linda Zedler *Institute of Physical Chemistry, Friedrich Schiller University Jena, Helmholtzweg 4, 07743, Jena, Germany.ORCID 0000-0002-0787-6625
Pascal Wintergerst *Institute of Inorganic Chemistry I, Materials and Catalysis, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.
Alexander K MengeleInstitute of Inorganic Chemistry I, Materials and Catalysis, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.ORCID 0000-0001-6496-3429
Carolin MüllerInstitute of Physical Chemistry, Friedrich Schiller University Jena, Helmholtzweg 4, 07743, Jena, Germany.ORCID 0000-0002-5968-2216
Chunyu LiInstitute of Physical Chemistry, Friedrich Schiller University Jena, Helmholtzweg 4, 07743, Jena, Germany.
Benjamin Dietzek-IvanšićInstitute of Physical Chemistry, Friedrich Schiller University Jena, Helmholtzweg 4, 07743, Jena, Germany. benjamin.dietzek@uni-jena.de.ORCID 0000-0002-2842-3537
Sven RauInstitute of Inorganic Chemistry I, Materials and Catalysis, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany. sven.rau@uni-ulm.de.ORCID 0000-0001-9635-6009

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unequivocal assignment of rate-limiting steps in supramolecular photocatalysts is of utmost importance to rationally optimize photocatalytic activity. By spectroscopic and catalytic analysis of a series of three structurally similar [(tbbpy)

Indexed as

NADNiacinamideCatalysisHydrogenationLigandsOxidation-ReductionLigandsNADNiacinamide

Identifiers

PMID35534473
PMCPMC9085789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.